Profile
ABCM VRTX REGN VRNA ARGX ALNY
Company Name Abcam plc Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Verona Pharma plc argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $5.52B $122.53B $81.42B $72.68B $51.58B $43.35B
Employees 1.76K 6.10K 15.16K 0.21K 1.60K 2.23K
CEO Alan Thomas Hirzel BS, Reshma Kewalramani Leonard S. Schleifer David S. Zaccardelli Timothy Van Hauwermeiren Yvonne L. Greenstreet
Ratings
ABCM VRTX REGN VRNA ARGX ALNY
Quant Rating Score 4 4 1 4 3
Quant Rating Buy Buy Strong Sell Buy Neutral
Trading
ABCM VRTX REGN VRNA ARGX ALNY
Last Close $23.99 $434.02 $704.31 $106.91 $929.61 $460.54
High 52 $23.99 $513.76 $788 $106.91 $929.61 $491.09
Low 52 $23.99 $366.54 $482.92 $37.86 $532.27 $224.58
Price vs. 52 Week High 0 % -15.52 % -10.62 % 0 % 0 % -6.22 %
Price vs. 52 Week Low 0 % 18.41 % 45.84 % 182.38 % 74.65 % 105.07 %
Total Return
ABCM VRTX REGN VRNA ARGX ALNY
1 Month Return 0 % 4.13 % 21.84 % 0 % 10.19 % -4.39 %
3 Month Return 0 % 11.32 % 22.74 % 1.06 % 40.57 % 0.8 %
6 Month Return 0 % -1.06 % 18.51 % 49.92 % 64.35 % 61.42 %
9 Month Return 0 % -6.08 % 3.57 % 66.4 % 45.48 % 84.22 %
YTD Return 0 % 7.78 % -1.13 % 130.21 % 51.16 % 95.72 %
1 Year Return 0 % -3.12 % -5.41 % 180.68 % 61.8 % 96.59 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ABCM VRTX REGN VRNA ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.45 % - - -
Dividend Paid and Capex Coverage Ration (TTM) 1.05 % 9.76 % 3.92 % -147.93 % 65.28 % 5.97 %
Dividend Per Share (TTM) - - 3.52 % - - -
Payout Ratio (TTM) - - 8.22 % - - -
Profitability
ABCM VRTX REGN VRNA ARGX ALNY
Gross Profit Margin TTM 71.21 % 86.28 % 86.27 % 95.15 % 65.82 % 83.99 %
Return on Assets TTM 0.45 % 14.78 % 11.11 % -11.01 % 15.06 % 0.9 %
Return on Equity TTM 0.76 % 21.81 % 14.83 % -30.05 % 18.96 % 26.13 %
Return on Capital Employed TTM 0.8 % 19.59 % 10.3 % -8.31 % 5.04 % 8.03 %
Net Income Per EBT TTM 93.62 % 82.61 % 86.12 % 111.64 % 237.3 % -136.38 %
EBT Per Ebit TTM 73.44 % 111.4 % 146.19 % 130.36 % 147.38 % -12.07 %
EBIT Per Revenue TTM 2.03 % 34.06 % 24.95 % -25.86 % 13.47 % 8.25 %
Cash Flow To Debt Ratio TTM 27.38 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Receivables Turnover TTM - 6.02 2.5 1.93 1.91 3.33
Payables Turnover TTM 7.04 0.4 2.1 2.37 0.9 4.37
Inventory Turnover TTM 1.56 0.99 0.62 0.94 2.26 6.82
Fixed Asset Turnover TTM 195.05 % 388.59 % 280.11 % 6536.22 % 5009.77 % 463.12 %
Asset Turnover TTM 31.98 % 47.15 % 35.36 % 29.27 % 31.97 % 66.16 %
Operating Cash Flow Per Share TTM 0.3 14.55 48.39 -0.85 5.67 2.02
Free Cash Flow Per Share TTM 0.01 13.06 39.66 -0.85 5.58 1.68
Cash Per Share TTM 45.81 % 2459.7 % 8362.68 % 511.43 % 5536.58 % 2072.79 %
Operating Cash Flow Sales Ratio TTM 19.94 % 31.71 % 34.71 % -43.23 % 17.54 % 8.28 %
Free Cash Flow Operating Cash Flow Ratio TTM 4.93 % 89.76 % 81.96 % 100.75 % 98.47 % 83.26 %
Cash Flow Coverage Ratios TTM 27.38 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Price To Free Cash Flows Ratio TTM - 36.72 19.95 -995.27 129.37 195.85
Price To Operating Cash Flows Ratio TTM 40.46 32.86 16.2 -126.33 146.05 162.25
Price Cash Flow Ratio TTM 40.46 32.86 16.2 -126.33 146.05 162.25
Income Statement (TTM)
ABCM VRTX REGN VRNA ARGX ALNY
Revenue $0.36B $11.02B $14.34B $0.03B $2.19B $2.25B
Gross Profit $0.27B $9.49B $12.24B $0.03B $1.96B $1.92B
Gross Profit Ratio 74.79% 86.11% 85.35% 93.89% 89.62% 85.62%
EBITDA $0.04B $0.49B $5.82B $-0.12B $0.11B $-0.18B
Net Income $-0.01B $-0.54B $4.5B $-0.14B $0.83B $-0.28B
EPS Diluted -0.04 -2.08 41.48 -1.73 12.78 -2.18
Balance Sheet (MRQ)
ABCM VRTX REGN VRNA ARGX ALNY
Long Term Debt $0.1B $1.66B $2.71B $0.12B $0.03B $2.59B
Total Liabilities $0.33B $6.12B $9.3B $0.27B $0.7B $4.17B
Total Equity $0.73B $16.41B $31.26B $0.2B $5.5B $0.07B
Total Investments $0B $6.65B $15.75B $0.02B $1.93B $1.73B
Total Debt $0.22B $1.75B $2.71B $0.12B $0.04B $2.74B
Total Assets $1.06B $22.53B $40.56B $0.47B $6.2B $4.24B
Cash Flow Statement (TTM)
ABCM VRTX REGN VRNA ARGX ALNY
Net Income $-0.01B $-0.54B $4.5B $-0.17B $0.83B $-0.28B
Inventory $-0.01B $-0.52B $-0.28B $-0.01B $-0.1B $0.01B
Dividends Paid $-0.03B $0B $-0.37B $0B $0B $0B
Operating Cash Flow $0.03B $-0.49B $4.98B $-0.12B $-0.08B $-0.01B
Capital Expenditure $-0.04B $-0.3B $-0.9B $-0B $-0.07B $-0.03B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 23.2
AARD Aardvark Therapeutics, Inc. Common Stock 12.28
ABCL AbCellera Biologics Inc. 2.94
ABEO Abeona Therapeutics Inc. 4.99
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.39
ABPWW 0.0131
ABSI Absci Corporation 2.42
ABUS Arbutus Biopharma Corporation 4.01
ABVC ABVC BioPharma, Inc. 1.67
ABVX Abivax SA American Depositary Shares 124.54
ACAD ACADIA Pharmaceuticals Inc. 21.61
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 6.72
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.13
ACIU AC Immune SA 2.93
ACLX Arcellx, Inc. 68.65
ETFs With Exposure to ABCM
Ticker ETF Name Weight Percentage Price
IBB iShares Biotechnology ETF 0.40175 170.64
SPDW SPDR Portfolio Developed World ex-US ETF 0.033598 48.65
BIB ProShares Ultra Nasdaq Biotechnology 0.189373 83.0913
MNA IQ Merger Arbitrage ETF 6.85 36.25
ONEQ Fidelity Nasdaq Composite Index ETF 0.01 88.98
FPXI First Trust International Equity Opportunities ETF 0.45 66.3464
ISCF iShares MSCI Intl Small-Cap Multifactor ETF 0.18111 45.04
MRGR ProShares Merger ETF 3.16608 44.695
FPXE First Trust IPOX Europe Equity Opportunities ETF 0.27 32.6697
VINEX Vanguard International Explorer Fund Investor Shares 0.22 21.96
VGHAX Vanguard Health Care Fund Admiral Shares 0.36 86.79
VGHCX Vanguard Health Care Fund Investor Shares 0.36 205.85
BMED BlackRock Future Health ETF 1.68229 30.35
IBBQ Invesco Nasdaq Biotechnology ETF 0.539 29.1392
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.48139 7.17
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.53798 8.4975
DFIC Dimensional International Core Equity 2 ETF 0.00052105 37.71
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF 0.53798 8.451
CTRU ARK Transparency ETF 0.96 12.897
Unlock